FIELD: medicine.
SUBSTANCE: laser applicators in the form of a uniformly distributed lattice are applied over the entire area of macular edema with the following laser exposure parameters: wavelength 577 nm, power 140-325 W, exposure 20-25 ns, duty cycle 10-12%, spot diameter 100 mcm, applicators number 125-475.
EFFECT: method allows to increase the efficiency of treatment, as well as to reduce side complications.
2 cl, 7 dwg, 2 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR CENTRAL SEROUS CHORIORETINOPATHY THERAPY | 2016 |
|
RU2629804C1 |
| METHOD OF TREATING PATIENTS WITH INCIPIENT SIGNS OF EPIRETINAL MEMBRANE | 2015 |
|
RU2571710C1 |
| COMPLEX METHOD OF MACULAR OEDEMA TREATMENT IN RETINAL VEIN OCCLUSIONS | 2019 |
|
RU2718847C1 |
| METHOD OF COMBINED LASER TREATMENT OF DIABETIC MACULAR OEDEMA | 2015 |
|
RU2578371C1 |
| METHOD OF TREATMENT OF MACULAR FOR AGE-RELATED MACULAR DEGENERATION | 2017 |
|
RU2647142C1 |
| METHOD OF CENTRAL SEROUS CHORIORETINOPATHY TREATMENT | 2022 |
|
RU2797276C1 |
| METHOD OF COMBINED LASER TREATMENT OF INITIAL STAGE OF EPIRETINAL FIBROSIS | 2016 |
|
RU2634684C1 |
| METHOD OF TREATMENT OF CHOROIDAL NEOVASCULATION | 2018 |
|
RU2676075C1 |
| METHOD OF TREATING MACULAR EDEMA WITH A LASER AT WAVE LENGTH 532 nm | 2019 |
|
RU2717368C1 |
| METHOD FOR COMBINATION THERAPY OF RETINOVASCULAR MACULAR OEDEMA | 2013 |
|
RU2527360C1 |
